Skip to search formSkip to main contentSkip to account menu

Myeloid Metaplasia

Known as: METAPLASIA MYELOID 
National Institutes of Health

Related topics

Related topics

7 relations
Bone marrow dysplasiaExtramedullary Hematopoiesis FunctionMYELODYSPLASTIC SYNDROMEPrimary Myelofibrosis

Broader (2)

MetaplasiaMyeloproliferative disease

Narrower (1)

Myelofibrosis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Somatic point mutations in RUNX1/CBFA2/AML1 are common in high‐risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia
Objective: Acquired somatic point mutations in RUNX1/CBFA2/AML1 have recently been described in a subset of patients with… 
Review
2002
Review
2002
Clinical and Pathological Criteria for the Diagnosis of Essential Thrombocythemia, Polycythemia Vera, and Idiopathic Myelofibrosis (Agnogenic Myeloid Metaplasia)
A set of clinical and pathological criteria for the diagnosis and staging of Philadelphia chromosome-negative myeloproliferative… 
Highly Cited
2002
Highly Cited
2002
Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study
Increased neoangiogenesis has been reported in myelofibrosis with myeloid metaplasia (MMM). Thus we studied the effects of… 
Highly Cited
2001
Highly Cited
2001
Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis.
Current therapeutic options for myeloid metaplasia with myelofibrosis (MMM) are limited. A pilot study was conducted of… 
Highly Cited
2000
Highly Cited
2000
Serious myeloproliferative reactions associated with the use of thalidomide in myelofibrosis with myeloid metaplasia.
Current treatment in myelofibrosis with myeloid metaplasia (MMM) is inadequate: only a small proportion of patients derive… 
Review
1994
Review
1994
Agnogenic myeloid metaplasia with extramedullary hematopoiesis and fibrosis in the lung. Report of two cases.
Agnogenic myeloid metaplasia (AMM) is a chronic hematologic disorder with a long clinical course, characteristically accompanied… 
Highly Cited
1991
Highly Cited
1991
Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia.
Myelofibrosis with myeloid metaplasia (MMM) belongs to the group of myeloproliferative syndromes. It is characterized by a… 
Highly Cited
1980
Highly Cited
1980
An Identical Translocation between Chromosome 1 and 7 in Three Patients with Myelofibrosis and Myeloid Metaplasia
Summary. An identical chromosome abnormality was observed in three unrelated patients with myelofibrosis and myeloid metaplasia… 
1977
1977
Recurrent pyoderma gangrenosum and agnogenic myeloid metaplasia.
Pyoderma gangrenosum has been associated with myelogenous leukemia and plasma cell dyscrasia. When associated with leukemia… 
Highly Cited
1964
Highly Cited
1964
MULTIPLE MYELOMA AND THE MYELOPROLIFERATIVE SYNDROMES.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)